Gavi vaccinates 86 million girls against HPV, exceeding its goal

Gavi has met its goal of vaccinating 86 million girls against HPV ahead of schedule, fulfilling a promise made in December 2022. This achievement significantly expands access to the life-saving vaccine in vulnerable countries, with an estimated 1 million lives to be saved and substantial economic benefits. The HPV vaccine, the first against cancer, protects against the leading cause of cervical cancer, a disease disproportionately affecting lower-income nations.